-
Views
-
Cite
Cite
Alfred Halstensen, Miroslav Ceska, Petter Brandtzaeg, Heinz Redl, Are Naess, Anders Waage, Interleukin-8 in Serum and Cerebrospinal Fluid from Patients with Meningococcal Disease, The Journal of Infectious Diseases, Volume 167, Issue 2, February 1993, Pages 471–475, https://doi.org/10.1093/infdis/167.2.471
Close - Share Icon Share
Abstract
To evaluate the role of interleukin (IL)-8 in meningococcal disease, a solid-phase double-ligand ELISA was used to quantitate IL-8 in sera and cerebrospinal fluid (CSF) from patients with meningococcal meningitis, bacteremia, or both with or without septic shock. IL-8 was demonstrated in sera from 28 of 62 patients; levels were significantly higher in patients with septic shock without meningitis (median, 36.1 ng/ml.) than in patients with other manifestations (median, <0.02 ng/ml.), and 4 of 5 patients who died had high levels. IL-8 was detected in all 27 CSF samples. Serum IL-8 levels correlated highly significantly with those of IL-6 (r= .83) and tumor necrosis factor (TNF; r = .64), while the correlations between corresponding CSF levels were less pronounced (r= .43 and r= .38, respectively) but still significant. Serum IL-8 levelswere highest in patients with a symptom history <12 h. The elimination rate of IL-8 from serum varied and was similar to that ofIL-6 and TNF. IL-8 appears to participate in the complex cytokine network during the initial phase of systemic meningococcal infections.
